Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation
Clinical trial NCT02737774 · UNKNOWN
Trial details
- NCT number
- NCT02737774
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-13
- Primary completion
- 2019-10-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.